104 related articles for article (PubMed ID: 11763526)
1. [Use of ednit in the treatment of portal hypertension in patients with chronic hepatitis and liver cirrhosis].
Maev IV; Kaziulin AN; Andreev NG; Aksel'rod AG; Nikushkina IN
Ter Arkh; 2001; 73(10):79-83. PubMed ID: 11763526
[TBL] [Abstract][Full Text] [Related]
2. Essential hypertension and chronic viral hepatitis.
Parrilli G; Manguso F; Orsini L; Coccoli P; Vecchione R; Terracciano L; De Luca N; Cirillo N; Abazia C; Budillon G; Marchesini G
Dig Liver Dis; 2007 May; 39(5):466-72. PubMed ID: 17369113
[TBL] [Abstract][Full Text] [Related]
3. [Effect of ACE inhibitor (ednit) on portal hemodynamics in patients with hepatic cirrhosis].
Postnikova TN; Larina EA; Berdnikov SV; Serov NA
Klin Med (Mosk); 1999; 77(12):46-7. PubMed ID: 10684217
[No Abstract] [Full Text] [Related]
4. [Hypotensive effectiveness of therapy combined enalapril and nitrendipine and influence on the quality of life].
Bryl W; Cymerys M; Kujawska-Luczak M; Pupek-Musialik D
Pol Merkur Lekarski; 2005 Mar; 18(105):287-90. PubMed ID: 15997634
[TBL] [Abstract][Full Text] [Related]
5. Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial.
Abraldes JG; Albillos A; Bañares R; Turnes J; González R; García-Pagán JC; Bosch J
Gastroenterology; 2009 May; 136(5):1651-8. PubMed ID: 19208350
[TBL] [Abstract][Full Text] [Related]
6. [Pharmacokinetic and pharmacodynamic characteristics of antihypertensive drugs in the treatment of hypertensive patients with chronic diseases of the liver].
Mikheeva OM; Drozdov VN; Komisarenko IA
Ter Arkh; 2011; 83(12):49-55. PubMed ID: 22416445
[TBL] [Abstract][Full Text] [Related]
7. [Correction of portal hypertension by beta-adrenoblockers (atenolol and metoprolol) and inhibitors of ACE (lisinopril and enalapril) in liver cirrhosis].
Lazebnik LB; Mikheeva OM; Toporkov AS; Komissarenko IA; Vasnev OS; Fedulenkova LV
Eksp Klin Gastroenterol; 2007; (5):57-66. PubMed ID: 18389599
[No Abstract] [Full Text] [Related]
8. [Drug therapy of pulmonary and portal hypertension in liver cirrhosis].
Vorob'ev LP; Maev IV; Andreev NG
Klin Med (Mosk); 1991 Feb; 69(2):64-7. PubMed ID: 1875666
[TBL] [Abstract][Full Text] [Related]
9. Disagreement between acute and chronic haemodynamic effects of nadolol in cirrhosis: a pathophysiological interpretation.
Merkel C; Bolognesi M; Sacerdoti D; Bombonato G; Cavasin L; Gatta A
Aliment Pharmacol Ther; 2005 Sep; 22(5):433-9. PubMed ID: 16128681
[TBL] [Abstract][Full Text] [Related]
10. [Correction of portal hypertension and renal dysfunction with help of nebivolol and lizinopril in patients with hepatic cirrhosis].
Fedulenkova LV
Eksp Klin Gastroenterol; 2009; (5):130-7. PubMed ID: 20201315
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacokinetics of enalapril and metoprolol in hypertensive patients with hepatic pathology].
Lazebnik LB; Mikheeva OM; Drozdov VN; Petrakov AV; Sil'vestrova SIu
Ter Arkh; 2007; 79(9):18-25. PubMed ID: 18038581
[TBL] [Abstract][Full Text] [Related]
12. Captopril reduces portal pressure effectively in portal hypertensive patients with low portal venous velocity.
Baik SK; Park DH; Kim MY; Choi YJ; Kim HS; Lee DK; Kwon SO; Kim YJ; Park JW; Chang SJ
J Gastroenterol; 2003; 38(12):1150-4. PubMed ID: 14714252
[TBL] [Abstract][Full Text] [Related]
13. [24-Hour arterial pressure profile in chronic obstructive lung diseases in combination with arterial hypertension treated with enalapril].
Ol'binskaia LI; Belov AA
Ter Arkh; 2002; 74(3):59-62. PubMed ID: 11980126
[TBL] [Abstract][Full Text] [Related]
14. [Ednit influence on oxidation resistance of LDL lipoproteins in hypertensive subjects].
Ragino IuI; Latyntseva LD; Ivanova MV
Ter Arkh; 1999; 71(8):21-3. PubMed ID: 10515029
[TBL] [Abstract][Full Text] [Related]
15. [Portal hypertension in chronic hepatitis (author's transl)].
Mörl M; Wannagat L; Gehring D
Z Gastroenterol; 1980 Feb; 18(2):83-8. PubMed ID: 7385937
[TBL] [Abstract][Full Text] [Related]
16. [Is it possible to predict a decrease in portal pressure after administration of ACE inhibitors?].
Svoboda P; Kantorová I; Ochmann J
Vnitr Lek; 1994 Mar; 40(3):170-3. PubMed ID: 8184570
[TBL] [Abstract][Full Text] [Related]
17. Portal pressure response to losartan compared with propranolol in patients with cirrhosis.
De BK; Bandyopadhyay K; Das TK; Das D; Biswas PK; Majumdar D; Mandal SK; Ray S; Dasgupta S
Am J Gastroenterol; 2003 Jun; 98(6):1371-6. PubMed ID: 12818283
[TBL] [Abstract][Full Text] [Related]
18. [The protein C system in chronic hepatic diseases, and anti-viral therapy].
Koroĭ PV
Klin Med (Mosk); 2008; 86(2):63-6. PubMed ID: 18368797
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological treatment of portal hypertension.
González-Abraldes J; Bosch J; García-Pagán JC
Curr Opin Investig Drugs; 2001 Oct; 2(10):1407-13. PubMed ID: 11890356
[TBL] [Abstract][Full Text] [Related]
20. Long term effects of propranolol on portal pressure in cirrhotic patients.
Orban-Schiopu AM; Popescu CR
Rom J Gastroenterol; 2003 Mar; 12(1):25-30. PubMed ID: 12673376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
